Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine in critically ill children in PICU
IRCT20221206056734N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in critical illness, sponsored by Tabriz University of Medical Sciences. Started Feb 2025; status: completed.
02
Drugs
levocarnitine
03
Conditions
critical illness
Beyond the preview
Go deeper on IRCT20221206056734N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221206056734N2.